These findings indicate that dysregulated turnover of versican and decorin alters levels of these proteoglycans in the lung ECM, a process that may be partially responsible for fibrotic manifestations of IPF, IIP, and COPD. The gene discussed is VCAN; the disease is chronic obstructive pulmonary disease.